Chisato Murata

404 total citations
21 papers, 289 citations indexed

About

Chisato Murata is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Chisato Murata has authored 21 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 7 papers in Epidemiology. Recurrent topics in Chisato Murata's work include Alcohol Consumption and Health Effects (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Diet and metabolism studies (6 papers). Chisato Murata is often cited by papers focused on Alcohol Consumption and Health Effects (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Diet and metabolism studies (6 papers). Chisato Murata collaborates with scholars based in Japan, United States and India. Chisato Murata's co-authors include Yoshihiko Suzuki, Kempei Matsuoka, Matsuo Taniyama, Yoshihito Atsumi, Tetsu Watanabe, Taro Muramatsu, Kazuhiro Hosokawa, Yasuhide Hayashi, Akira Shimada and Isao Okazaki and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Chisato Murata

21 papers receiving 285 citations

Peers

Chisato Murata
Udo Wendel Germany
Boniface Obiako United States
Abha Aggarwal United States
Oana Milaş Romania
G. W. L�hr Germany
Chisato Murata
Citations per year, relative to Chisato Murata Chisato Murata (= 1×) peers Chuan‐Hong Kao

Countries citing papers authored by Chisato Murata

Since Specialization
Citations

This map shows the geographic impact of Chisato Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chisato Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chisato Murata more than expected).

Fields of papers citing papers by Chisato Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chisato Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chisato Murata. The network helps show where Chisato Murata may publish in the future.

Co-authorship network of co-authors of Chisato Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Chisato Murata. A scholar is included among the top collaborators of Chisato Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chisato Murata. Chisato Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sano, Hirozumi, Akira Shimada, Ken Tabuchi, et al.. (2013). WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group. International Journal of Hematology. 98(4). 437–445. 12 indexed citations
2.
Sano, Hirozumi, Akira Shimada, Tomohiko Taki, et al.. (2012). RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. International Journal of Hematology. 95(5). 509–515. 32 indexed citations
3.
Shiba, Norio, Daisuke Hasegawa, Hyuntae Park, et al.. (2011). CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML). Blood. 119(11). 2612–2614. 40 indexed citations
4.
Hosokawa, Kazuhiro, Shu Meguro, Osamu Funae, et al.. (2009). Clinical effects of metformin in patients with nonobese type 2 diabetes. 52(1). 1–6. 3 indexed citations
5.
Nakamura, Kaori, Chisato Murata, Masanori Ito, et al.. (2006). Design of Hammerhead Ribozymes that Cleave Murine Sry mRNA In Vitro and In Vivo. Journal of Reproduction and Development. 52(1). 73–80. 2 indexed citations
6.
Ito, Masanori, Makoto Miyagishi, Chisato Murata, et al.. (2006). Down-Regulation of Endogenous Wt1 Expression by Sry Transgene in the Murine Embryonic Mesonephros-Derived M15 Cell Line. Journal of Reproduction and Development. 52(3). 415–427. 4 indexed citations
7.
Watanabe, Tetsu, Chisato Murata, & Yoshihisa Watanabe. (2005). Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease.. PubMed. 52(11). 934–42. 7 indexed citations
8.
Murata, Chisato, et al.. (2005). Association of change in the type of job with prevalence of components of the metabolic syndrome-special reference to job stress.. PubMed. 52(11). 987–93. 9 indexed citations
9.
Ishikawa, Noriko, Chisato Murata, Shun Ito, et al.. (2005). Change of components of the metabolic syndrome in a workers' health checkup after five years--relation with elevated liver enzymes, gene polymorphisms for ALDH 2, beta3-AR and lifestyle.. PubMed. 52(11). 979–86. 1 indexed citations
10.
Suzuki, Yoshihiko, Y. Oka, Matsuo Taniyama, et al.. (2004). A case of type 2 diabetes with high levels of plasma and urinary C-peptide. Diabetes Research and Clinical Practice. 66. S125–S128. 4 indexed citations
11.
Murata, Chisato, Matsuo Taniyama, Satoru Kuriyama, et al.. (2004). Meta-analysis of three diabetes population studies: association of inactive ALDH2 genotype with maternal inheritance of diabetes. Diabetes Research and Clinical Practice. 66. S145–S147. 15 indexed citations
12.
Murata, Chisato, Tetsu Watanabe, Hiroyuki Furuya, et al.. (2003). Aldehyde dehydrogenase 2 and β3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome. Metabolism. 52(9). 1096–1101. 22 indexed citations
13.
Momiyama, Yukihiko, Michiko Furutani, Yoshihiko Suzuki, et al.. (2003). A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes. Biochemical and Biophysical Research Communications. 312(3). 858–864. 15 indexed citations
14.
Murata, Chisato, Yoshihiko Suzuki, Taro Muramatsu, et al.. (2000). Inactive Aldehyde Dehydrogenase 2 Worsens Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Drink Low to Moderate Amounts of Alcohol. Alcoholism Clinical and Experimental Research. 24(S4). 5S–11S. 27 indexed citations
15.
Suzuki, Yoshihiko, Matsuo Taniyama, Toshiki Muramatsu, et al.. (1997). Diabetes mellitus associated with 3243 mitochondrial tRNALeu(UUR) mutation: Clinical features and coenzyme Q10 treatment. Molecular Aspects of Medicine. 18. 181–188. 24 indexed citations
16.
Suzuki, Yoshihiko, Toshiki Muramatsu, Matsuo Taniyama, et al.. (1996). Association of aldehyde dehydrogenase with inheritance of NIDDM. Diabetologia. 39(9). 1115–1118. 22 indexed citations
17.
Suzuki, Yoshihiko, Taro Muramatsu, Matsuo Taniyama, et al.. (1996). Mitochondrial Aldehyde Dehydrogenase in Diabetes Associated With Mitochondrial tRNALeu(UUR) Mutation at Position 3243. Diabetes Care. 19(12). 1423–1425. 22 indexed citations
18.
19.
Suzuki, Yoshihiko, Hiroko Kadowaki, Yoshihito Atsumi, et al.. (1995). A Case of Diabetic Amyotrophy Associated with 3243 Mitochondrial tRNA(leu; UUR) Mutation and Successful Therapy with Coenzyme Q10.. Endocrine Journal. 42(2). 141–145. 21 indexed citations
20.
Murata, Chisato, et al.. (1993). Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.. The Journal of Clinical Endocrinology & Metabolism. 77(2). 464–470. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026